Picture of Tourmaline Bio logo

TRML — Tourmaline Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Talaris Therapeutics Announces Plans To Explore Strategic Alternatives And Implements Restructuring Plan

Feb 16 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES PLANS TO EXPLORE STRATEGIC
ALTERNATIVES AND IMPLEMENTS RESTRUCTURING PLAN
    * TALARIS THERAPEUTICS INC - TO DISCONTINUE ITS FREEDOM-1
AND
FREEDOM-2 CLINICAL TRIALS
    * TALARIS THERAPEUTICS INC - WILL CONTINUE TO ENROLL ITS
FREEDOM-3
PHASE 2 CLINICAL TRIAL
    * TALARIS THERAPEUTICS INC- RESTRUCTURING PLAN  INCLUDES
REDUCING
ITS WORKFORCE BY APPROXIMATELY ONE-THIRD
    * TALARIS THERAPEUTICS INC - WILL SUSPEND FURTHER GUIDANCE
ON
STATUS OF ITS PROGRAMS

Source text for Eikon:  ID:nGNXdy6lp 
Further company coverage:  TALS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Tourmaline Bio

See all news